← All compounds
metabolite0 listings
PEA
Palmitoylethanolamide
Endogenous fatty acid amide. Anti-inflammatory and pain research.
Anti-inflammatory researchAnalgesic research
/ research index
The research base
Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★☆☆
3/5 — Quality of evidence
Researched for anti-inflammatory research.
/ mechanism of action
How it works
Endocannabinoid-like lipid mediator; modulates inflammation and pain via PPAR-alpha.
/ research dosing
Common research protocols
Range
300-1200 mg/day
Frequency
Split daily, oral
Route
Oral
Cycle
Ongoing research use
Research notes
Naturally occurring lipid; micronized forms improve absorption.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Standalone oral research compound.
/ side effects
What to know
Generally well-tolerated; see research notes.
/ timeline
Realistic expectations
Weeks to months
FOR RESEARCH USE ONLY. PEA is intended for laboratory research and not for human consumption.